Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

被引:9
作者
Marrari, Marilyn
Duquesnoy, Rene J. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Div Transplant Pathol, Pittsburgh, PA 15260 USA
基金
美国国家卫生研究院;
关键词
HLAMatchmaker; HLA; Epitope structure; Eplet; Allograft nephrectomy; MOLECULARLY BASED ALGORITHM; HISTOCOMPATIBILITY DETERMINATION; EPITOPE ANALYSIS; HLA-DR; HLAMATCHMAKER; IMMUNOGENICITY; TRANSPLANTATION; DQ;
D O I
10.1016/j.humimm.2009.03.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLAMatchmaker is a matching algorithm that can be used to characterize antibodies specific for structurally defined epitopes. Under the auspices of the 15(th) International Histocompatibility Workshop, we are conducting a multilaboratory collaborative project to characterize these epitopes and also to determine how often they induce specific antibodies in patients with rejected kidney transplants. This report addresses the reactivity of post-allograft nephrectomy sera tested for DRB antibodies with Luminex assays using single alleles. This analysis was performed for 19 informative kidney transplant cases contributed by 13 laboratories worldwide. There were 11 cases with a single DR2 mismatch (DR15 or DR16), and nine of them (82%) showed antibodies with both DR2 and DR1. Although these antigens might share an epitope recognized by these antibodies, this interpretation is incorrect. The HLAMatchmaker analysis offers a clearly different explanation that involves antibodies induced by DR51, which commonly associates with DR2. DR51 has an epitope defined by the 96EV eplet, which is also present on DR1 but no other DR antigen. This means that the reactivity with DR51 and DR1 reflects the presence of 96EV-specific antibodies. Conversely, we analyzed eight patients sensitized by a single DR1 mismatch that has no associated DR51. All of these patients reacted also with DR51, and this could be explained only by antibodies against the shared 96EV eplet. These findings demonstrate that 96EV represents a highly immunogenic epitope that can induce cross-sensitization between antigens encoded by the different DRB loci, and also that DR51 is important in determining DRB mismatch acceptability of potential donors. This analysis has also demonstrated that antibody responses are restricted to a few epitopes on these immunizing DR antigens. For DR2 they are 142M3 (unique for DR2), 71QAA (shared with DB5*02), and 96QV (shared with DR10). DR51 mismatches appear to have three immunogenic eplets: 96EV (shared with DR1), 108T3 (unique for DR51), and 40HFD (shared with DR9). Immunogenic eplets on DR1 are 12LKF2 (unique for DR1), 14FEH (shared with DR9 and DR10), and 25HRL (shared with DR10). (C) 2009 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 23 条
  • [1] Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches
    Adeyi, OA
    Girnita, AL
    Howe, J
    Marrari, M
    Awadalla, Y
    Askar, M
    Martell, J
    Zeevi, A
    Shapiro, R
    Nalesnik, M
    Randhawa, P
    Demetris, AJ
    Duquesnoy, RJ
    [J]. TRANSPLANT IMMUNOLOGY, 2005, 14 (01) : 53 - 62
  • [2] [Anonymous], TRANSPL INT
  • [3] Cai Junchao, 2006, Clin Transpl, P103
  • [4] Common and well-documented HLA alleles -: Report of the ad-hoc committee of the American Society for Histocompatiblity and Immunogenetics
    Cano, Pedro
    Klitz, William
    Mack, Steven J.
    Maiers, Martin
    Marsh, Steven G. E.
    Noreen, Harriet
    Reed, Elaine F.
    Senitzer, David
    Setterholm, Michelle
    Smith, Anajane
    Fernandez-Vina, Marcelo
    [J]. HUMAN IMMUNOLOGY, 2007, 68 (05) : 392 - 417
  • [5] Differential immunogenicity of HLA mismatches in clinical transplantation
    Claas, FHJ
    Dankers, MK
    Oudshoorn, M
    van Rood, JJ
    Mulder, A
    Roelen, DL
    Duquesnoy, RJ
    Doxiadis, IIN
    [J]. TRANSPLANT IMMUNOLOGY, 2005, 14 (3-4) : 187 - 191
  • [6] The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome
    Claas, FHJ
    Witvliet, MD
    Duquesnoy, RJ
    Persijn, GG
    Doxiadis, IIN
    [J]. TRANSPLANTATION, 2004, 78 (02) : 190 - 193
  • [7] The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens
    Dankers, MKA
    Witvliet, MD
    Roelen, DL
    De Lange, P
    Korfage, N
    Persijn, GG
    Duquesnoy, R
    Doxiadis, IIN
    Claas, FHJ
    [J]. TRANSPLANTATION, 2004, 77 (08) : 1236 - 1239
  • [8] 14th International HLA and Immunogenetics Workshop: Report on the structural basis of HLA compatibility
    Duquesnoy, R. J.
    Claas, F. H. J.
    [J]. TISSUE ANTIGENS, 2007, 69 : 180 - 184
  • [9] Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes
    Duquesnoy, Rene J.
    Awadalla, Yehia
    Lomago, Jon
    Jelinek, Larry
    Howe, Judy
    Zern, Dwayne
    Hunter, Betty
    Martell, Joan
    Girnita, Alin
    Zeevi, Adriana
    [J]. TRANSPLANT IMMUNOLOGY, 2008, 18 (04) : 352 - 360
  • [10] HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP
    Duquesnoy, Rene J.
    Askar, Medhat
    [J]. HUMAN IMMUNOLOGY, 2007, 68 (01) : 12 - 25